CDC Reduces COVID-19 Fatality Rate to 0.26 Percent
In a new document providing guidance for public health officials on COVID-19, the U.S. Centers for Disease Control and Prevention (CDC) estimates the infection fatality rate (IFR) for the disease at 0.4 percent, or about half the nearly one percent fatality rate the CDC estimated in March 2020 when it was predicting up to 1.7 […]
Volunteer Describes His Serious Reaction in Moderna’s mRNA COVID-19 Vaccine Trial
Of the 45 volunteers in biotechnology company Moderna, Inc.’s Phase 1 human clinical trial on its experimental mRNA-1273 vaccine for COVID-19, only the names of the first two participants have been widely publicized—Jennifer Haller of Seattle, Washington and Neal Browning of Bothell, Washington. The clinical trial began on Mar. 16, 2020 at Kaiser Permanente Washington […]
Healthy Clinical Trial Subjects Suffer Grade 3 Side Effects to Moderna’s mRNA COVID-19 Vaccine
On May 18, 2020, Moderna, Inc. of Cambridge, Massachusetts announced that it had obtained “positive interim clinical data” from a Phase 1 human clinical trial of its experimental mRNA-1273 COVID-19 vaccine that began on Mar. 16. The biotechnology company said that eight of the 45 healthy adult volunteer trial subjects developed antibodies that may provide […]
Autism Numbers Increase by 8.5 Percent in U.S.
According to the U.S. Centers for Disease Control and Prevention (CDC), the number of children diagnosed with autism in the United States continues to increase. In a report published on Mar. 27, 2020, the CDC estimated the prevalence of autism spectrum disorder (ASD) in the country is now 1 in 54 children—up from 1 in […]
Fauci Says Rushing COVID-19 Vaccine is Risky
During a remote online testimony before the U.S. Senate’s Health, Education, Labor and Pensions Committee on May 12, 2020, Anthony Fauci, MD warned that moving forward too quickly with the development of a vaccine for COVID-19 may produce a vaccine that could make the disease worse.1 2 Dr. Fauci, who is the director of the […]
Pfizer/BioNTech Target Fall 2020 for COVID-19 Vaccine Availability
In recent weeks Inovio Pharmaceuticals of Pennsylvania and representatives of the German biotechnology firm CureVac AG and the University of Oxford in the United Kingdom have announced that their experimental COVID-19 vaccines will be ready for use by September 2020. On Apr. 29, 2020, Pfizer, Inc. of New York stated in a news release that […]